Valneva SE
VALNDrugs in Pipeline
5
Phase 3 Programs
3
Upcoming Catalysts
1
Next Catalyst
Aug 13, 2026
10dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
VALN Earnings Report
EPS Est: $-0.28 | FQ end 2026-06 | Call: 2026-08-13 15:00:00
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Valneva SE's drug pipeline?→
CatalystAlert tracks 5 drug candidates in Valneva SE's (VALN) pipeline across Phase 3, Phase 2. Its lead program is VLA2001 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Valneva SE's next FDA catalyst?→
Valneva SE's (VALN) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track VALN biotech catalysts?→
Add VALN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Valneva SE's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.